Evidence map›Paper›PMID 31969385›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2020

Chronic Methadone Use Alters the CD8

Claire Mazahery, Bryan L Benson, Angélica Cruz-Lebrón, Alan D Levine

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Claire MazaheryDepartment of Pathology, Case Western Reserve University, Cleveland, OH 44106.ORCID 0000-0002-9950-5433
Bryan L BensonDepartment of Pathology, Case Western Reserve University, Cleveland, OH 44106.ORCID 0000-0003-4318-5693
Angélica Cruz-LebrónDepartment of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, OH 44106.ORCID 0000-0002-7419-7382
Alan D LevineDepartment of Pathology, Case Western Reserve University, Cleveland, OH 44106; alan.levine@case.edu.ORCID 0000-0002-5706-0667
Case Western Reserve University · US

Funding

WG3: HIV, Co-infections and Co-morbiditiesP30AI036219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI Alan David Levine · 1994 to 2026
$50.0M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
Identification of immune protective pathways dysregulated by opioid use in HIV infection, using a systems biology-based approach, toward the goal of pharmacological restoration of immune functionR01DA043253 · NIDA · CASE WESTERN RESERVE UNIVERSITY · PI LEVINE, ALAN DAVID · 2016 to 2021
$4.3M
Repairing the intestinal epithelium from the dual action of HIV and drug useDP1DA037997 · NIDA · CASE WESTERN RESERVE UNIVERSITY · PI LEVINE, ALAN DAVID · 2015 to 2019
$4.1M
Immunology Training Program-PredoctoralT32AI089474 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI COBB, BRIAN A · 2010 to 2025
$3.4M
NRSA Training CoreTL1TR002549 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI HARDING, CLIFFORD V · 2018 to 2022
$2.9M
Case Western Reserve University/Cleveland Clinic CTSA (TL1)TL1RR024991 · NCRR · CASE WESTERN RESERVE UNIVERSITY · PI DAVIS, PAMELA B · 2007 to 2011
$2.1M
Training in Neurodegenerative DiseasesT32NS077888 · NINDS · CASE WESTERN RESERVE UNIVERSITY · PI Xiongwei Zhu · 2013 to 2026
$1.8M
Using Microfluidics to Investigate Mechanisms of Leukocyte Intravascular CrawlingF31NS096857 · NINDS · CASE WESTERN RESERVE UNIVERSITY · PI BENSON, BRYAN LAUCK · 2017 to 2018
$69k
NCATS NIH HHS TL1 TR002549NCRR NIH HHS TL1 RR024991NIAID NIH HHS P30 AI036219NIAID NIH HHS T32 AI089474NIDA NIH HHS DP1 DA037997NIDA NIH HHS R01 DA043253NIGMS NIH HHS T32 GM007250NINDS NIH HHS F31 NS096857NINDS NIH HHS T32 NS077888
6 · The paper itself

Abstract

Endogenous opioid peptides are released at sites of injury, and their cognate G protein-coupled opioid receptors (ORs) are expressed on immune cells. Although drugs of misuse appropriate ORs, conflicting reports indicate immunostimulatory and immunosuppressive activity, in that opioid users have elevated infection risk, opioids activate innate immune cells, and opioids attenuate inflammation in murine T cell-mediated autoimmunity models. The i.v. use of drugs transmits bloodborne pathogens, particularly viruses, making the study of CD8

Indexed as

Immunologic MemoryAntigens, CDAntigens, Differentiation, T-LymphocyteCD69 AntigensCD8-Positive T-LymphocytesChronic DiseaseFemaleHumansInterleukin-2 Receptor alpha SubunitLectins, C-TypeMaleMethadoneReceptors, AntigenReceptors, OpioidSignal TransductionSubstance-Related DisordersAntigens, CDAntigens, Differentiation, T-LymphocyteCD69 AntigensIL2RA protein, humanInterleukin-2 Receptor alpha SubunitLectins, C-TypeMethadoneReceptors, AntigenReceptors, Opioid

Identifiers

PMID31969385
PMCPMC7757720
OpenAlexW3001520232

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.